Negotiators from 11 countries have been racing to resurrect the near-dead Trans-Pacific Partnership Agreement before the Asia-Pacific Economic Cooperation (APEC) summit this weekend.
The latest plan to get the controversial trade deal up and running again after the withdrawal of the United States involves freezing some of its controversial rules. These include rules for biologic drugs, an expensive class of medicines often used to treat conditions such as cancer and rheumatoid arthritis.
Many communities globally are facing considerable changes to employment conditions as economies lose their traditional manufacturing base and attempt to transition to an economy based on advanced manufacturing and knowledge based industries.
Opinion piece by Ashley Schram in The Conversation
RegNet scholars showcase latest research
Professor Fran Baum, Matthew Flinders Distinguished Professor of Public Health, and Director of the Southgate Institute of Health, Society and Equity at Flinders University has joined RegNet as Hon